The potential benefits of longacting injectable cabotegravir in pregnant and breastfeeding women and their infants

Simple item page
dc.article.end-page594en
dc.article.start-page589en
dc.citation.doi10.1097/QAD.0000000000003803en
dc.contributor.authorL Johnsonen
dc.contributor.authorL Myeren
dc.contributor.authorL Jamiesonen
dc.contributor.authorG Meyer-Rathen
dc.contributor.authorAnn Delany-Moretlween
dc.contributor.authorD Joseph Daveyen
dc.date.accessioned2024-11-18T10:50:00Z
dc.date.available2024-11-18T10:50:00Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0269-9370en
dc.identifier.urihttps://hdl.handle.net/10539/42673
dc.journal.titleThe potential benefits of longacting injectable cabotegravir in pregnant and breastfeeding women and their infantsen
dc.journal.volume38en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleThe potential benefits of longacting injectable cabotegravir in pregnant and breastfeeding women and their infantsen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
162.14 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)